August 14, 2019

Weaponizing Biotech: How China’s Military Is Preparing for a ‘New Domain of Warfare’

By Elsa B. Kania and Wilson VornDick

Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement, and more.

We may be on the verge of a brave new world indeed. Today’s advances in biotechnology and genetic engineering have exciting applications in medicine — yet also alarming implications, including for military affairs. China’s national strategy of military-civil fusion (军民融合) has highlighted biology as a priority, and the People’s Liberation Army could be at the forefront of expanding and exploiting this knowledge.

The PLA’s keen interest is reflected in strategic writings and research that argue that advances in biology are contributing to changing the form or character (形态) of conflict. For example:

  • In 2010’s War for Biological Dominance (制生权战争), Guo Jiwei (郭继卫), a professor with the Third Military Medical University, emphasizes the impact of biology on future warfare.
  • In 2015, then-president of the Academy of Military Medical Sciences He Fuchu (贺福初) argued that biotechnology will become the new “strategic commanding heights” of national defense, from biomaterials to “brain control” weapons. Maj. Gen. He has since become the vice president of the Academy of Military Sciences, which leads China’s military science enterprise.
  • Biology is among seven “new domains of warfare” discussed in a 2017 book by Zhang Shibo (张仕波), a retired general and former president of the National Defense University, who concludes: “Modern biotechnology development is gradually showing strong signs characteristic of an offensive capability,” including the possibility that “specific ethnic genetic attacks” (特定种族基因攻击) could be employed.
  • The 2017 edition of Science of Military Strategy (战略学), a textbook published by the PLA’s National Defense University that is considered to be relatively authoritative, debuted a section about biology as a domain of military struggle, similarly mentioning the potential for new kinds of biological warfare to include “specific ethnic genetic attacks.”

Read the full article in Defense One.

  • Commentary
    • Foreign Affairs
    • January 14, 2022
    Washington’s Missing China Strategy

    The Biden administration has repeatedly identified China as the United States’ foremost foreign policy challenge. Secretary of Defense Lloyd Austin has referred to China as th...

    By Richard Fontaine

  • Reports
    • October 7, 2021
    Tangled Threats

    Executive Summary China and North Korea pose intertwined challenges for U.S. and allied policy. The Korean Peninsula constitutes just one area among many in U.S.-China relatio...

    By Jacob Stokes

  • Commentary
    • The Washington Post
    • September 22, 2021
    The Biden administration just stalled China’s advance in the Indo-Pacific

    Australia, by intensifying the military competition with China, could tee up a chain of as yet unforeseen events....

    By Robert D. Kaplan

  • Commentary
    • Asia Times
    • September 11, 2021
    China tariff policies flounder without a strategy

    The White House ought to be asking a series of questions. What problem are we responding to? What are we trying to achieve? How will 301s and tariffs further that?...

    By Van Jackson

View All Reports View All Articles & Multimedia